Summary A rat thyroid cancer cell line, FRTC, was established from the normal rat thyroid cell line, 
Previous studies have shown that thyroid tumours can be produced in vivo in rats by feeding thiouracil (Wollman, 1963) or 131' followed by a low-iodine diet (Volpert and Prezyna, 1977) . Recently, there have been several reports regarding the in vitro generation of mutant cells from the normal rat thyroid cell line, (Ambesi-Impiombato et al, 1980) . FRTL-5 has many characteristics of thyroid epithelial cells, such as thyroglobulin (Tg) synthesis, iodine concentration and thyroid-stimulating hormone (TSH)-dependent cell growth. However, after the establishment of mutated FRTL-5 cells by various methods, such as chemical mutagenesis (Tramontano et al, 1986a; Sugawa et al, 1989) , transformation with virus, oncogenes or human TSH receptor cDNA (Fusco et al, 1981 (Fusco et al, , 1987 Ferrentino et al, 1984; Berlingieri et al, 1990; Derwahl et al, 1992) or cellular cloning (Endo et al, 1990 ), many of these cells have lost TSH-dependent growth and their differentiation markers. On the other hand, human thyroid cancers are often characterized by well-differentiated features that include Tg production and expression of Tg, thyroid peroxidase (TPO) and TSH receptor mRNA. (Brabant et al, 1991; Ohta et al, 1991) .
N-acetyl-muramyl-L-alanyl-D-isoglutamine (hereafter referred to as MDP for muramyl dipeptide) has been shown to have the minimal structure required for the adjuvant activity of mycobacteria as demonstrated by stimulation of enhanced immune responses in vivo and in vitro (Ellouz et al, 1974; Lefrancier et al, 1977; Specter et al, 1977) . During our preliminary study using MDP as adjuvant in the co-culture of FRTL-5 cells and Fisher rat spleen cells in vitro, we have found that these cells formed tumours when they were transplanted in Fisher rats. We then confirmed that the tumour was of epithelial cell origin, and spleen cells were not necessary to induce the tumour. We report here the MDP-mediated in vivo transformation of FRTL-5 cells to cancer cells (FRTC) . FRTC retained various characteristics of a welldifferentiated thyroid carcinoma. FRTC responded to TSH stimulation to produce Tg and cAMP, and expressed Tg, TPO and TSH receptor mRNA. However, the growth of FRTC was independent of TSH.
MATERIALS AND METHODS
Cell culture FRTL-5 cells (donated by Dr Kohn, NIH, in 1987) were maintained in Ham's F-12 medium supplemented with 5% calf serum and six hormones (6H medium), as described previously (AmbesiImpiombato et al, 1980) . FRTL-5 cells were cultured in 6H medium in the presence or absence of 20 mg 1-' MDP (Sigma, St Louis, USA) for 4 days at 37°C in 5% carbon dioxide. Cells were harvested after dispase digestion and 3 x 105 cells were injected intraperitoneally into Fisher rats. One month after the transplantation, disseminated peritoneal tumour was collected and digested with collagenase. Cells were then washed, suspended in the 6H medium and cultured in a plastic flask (Nunc, Roskilde, Denmark). As we found that the proliferation of these cells (FRTC) was independent of six hormones, Ham's F-12 medium supplemented only with 5% calf serum was used to maintain FRTC cells. Unless otherwise stated, FRTC cells of the third generation were used for the experiments. (Yanagisawa et al, 1986; litaka et al, 1991 Gifford, 1984) . The cAMP content of supernatants after 3 h exposure to various stimuli was measured by radioimmunossay using commercially available kits (Yamasa, Tokyo, Japan). Incorporation of 13'I was assessed as described previously (Ambesi-Impionbato et al, 1980) . mRNA expression Total RNA was extracted from FRTC tumours and FRTL-5 and FRTC cells as described previously (Chomczynski and Sacchi, 1987) . When cells were used, they were seeded in 100-mm Petri dishes and cultured in 5H medium supplemented with 5% calf serum. Some cells were stimulated with 10 U 1-1 TSH for 24 h. In some experiments, total RNA was further purified with an oligodT cellulose column (Pharmacia, Uppsala, Sweden). Expression of various mRNAs was analysed by Northern blot hybridization using 10 gg of total RNA (for Tg, TPO, cyclophilin and 3-actin) or 3 jig of poly-A RNA (for Tg, TPO, TSH receptor, c-mvc, c-fos and cyclophilin). Rat Tg cDNA (a gift from Dr DiLauro, European Molecular Biology Laboratory in 1988), rat TPO cDNA (Dr Rapoport, University of Califomnia, San Francisco, USA), rat TSH receptor cDNA (Dr Akamizu, Kyoto University, Japan; Dr Kohn, NIH, USA), rat cyclophilin cDNA (Dr Sutcliffe, Research Institute of Scripps Clinic, La Jolla, USA), v-myc and v-fos (Japanese Cancer Research Resources Bank) and f8-actin cDNA (Nippon Gene, Tokyo, Japan) were used for hybridization. After the transfer of RNA, the membrane (Gene Screen Plus, Biotechnology Systems, Boston, USA) was incubated at 42°C for 15 min in 2 x standard saline citrate buffer (1 x SSC: 8.77 g sodium chloride, 4.41 g sodium citrate in 11 of water), followed by the addition of a labelled probe (T7 Quick Prime kit, Pharmacia). The final washing British Journal of Cancer (1997) 75(1) Figure  IA ). There was no histological difference in the tumours obtained on these three different occasions. There were colloid-like structures ( Figure 1B ) filled with Tg-positive material (Figure 2A) . Figure 2B shows the thyroid follicles that were obtained from the same rat as shown in Figure lB and stained with anti-Tg antibodies. Neither this colloid-like material nor real colloid in the rat thyroid was stained with antibodies to rat lymphocyte surface antigens, such as OX6, OX8 or W3/25 (data not shown). The tumour was digested and the cells were cultured in vitro. These cells (FRTC) also formed large encapsulated tumours in Fisher rats when transplanted subcutaneously (Figure 3) Figure 7 ). The expression of Tg mRNA decreased in the tumour of FRTC of the 12th generation compared with that in the tumour of the third generation (Figure 8 ). On the other hand, there was no significant change in TSH receptor mRNA levels between these tumours (Figure 8 ). It is of interest that c-myc and c-fos mRNA were consistently expressed in FRTC cells in vivo as well as in vitro. Expression of these proto-oncogenes was more prominent in vivo than in vitro (Figures 9 and 10) . TSH did not enahnce the expression of c-myc or c-fos in FRTC cells (Figures 9 and 10) . The expression of c-myc in FRTL-5 cells was not enhanced by MDP stimulation for 4 days (Figure 9 ).
DISCUSSION
There have been several reports on the transformation of FRTL-5 cells with virus and/or active oncogenes (Fusco et al, 1981 (Fusco et al, , 1985 (Fusco et al, , 1987 Ferrentino et al, 1984; Berlingieri et al, 1990) , chemical agents (Tramontano et al, 1986a; Sugawa et al, 1989) human TSH receptor cDNA (Derwahl et al, 1992) . We have gener- This result indicates that MDP may have a carcinogenic effect similar to ethyl methane sulphonate, a chemical mutagenic agent, which has been used to transform FRTL-5 cells (Tramontano et al, 1986a; Sugawa et al, 1989) . However, MDP did not transform FRTL-5 cells in vitro, and tumours did not develop after the administration of MDP to Fisher rats (M litaka et al, unpublished data). MDP, also referred to as an adjuvant peptide, has been shown to stimulate T cells and macrophages (Ellouz et al, 1974; Lefrancier et al, 1977; Specter et al, 1977) . There have been no previous reports concerning a possible carcinogenic effect of MDP on thyroid cells. We found that MDP had no stimulatory effect on FRTL-5 cells in vitro in terms of [3H]TdR incorporation, cAMP production or c-myc expression. Since untreated FRTL-5 cells did not develop tumours, and the chromosomal heterogeneity and rearrangements in FRTC were evident as assessed by the karyotype analysis, MDP must have acted as a carcinogen or a tumourpromoting agent. Tramontano et al (1986) have found it necessary to use chemical mutagenesis to isolate TSH-independent clones from FRTL-5 cells because of the very low rate of spontaneous mutational events. However, Endo et al (1990) have successfully isolated a spontaneously transformed cell line from commercially available FRTL cells. This discrepancy may be a result of the difference of the cells. Similar to the previous report (Davies et al, 1987) , our FRTL-5 cells also had the chromosomal heterogeneity. Huber et al (1990) have reported that there is extreme individual heterogeneity in human thyroid cells as well as FRTL-5 cells. They concluded that each thyroid cell has a highly variable growth programme, and non-transformed immortal cell lines in vitro may represent one end of a spectrum of individual growth potential among normal thyrocytes. In addition to such a high growth potential, some in vivo growth factor(s) in Fisher rats might have promoted the proliferation of transformed FRTL-5 cells in this study. Previous studies by Wollman (1963) have shown that thiouracil, a goitrogenic agent, promoted tumour formation of the thyroid gland in rats. Others have also reported that propylthiouracil, an anti-thyroid drug, greatly increased the incidence of thyroid tumour formation when rats were treated with N-bis(2-hydroxypropyl) nitrosamine (Kitahori et al, 1982) or the Kirsten murine sarcoma virus (Portella et al, 1989) . As these goitrogenic agents induce the elevation of serum TSH levels, TSH may act as one of the tumour-promoting factors in those rats. Although the precise mechanism for the generation of FRTC cells with MDP treatment remains to be clarified, it is of interest that MDP, a ubiquitously present bacterial wall peptide, may act as a tumourpromoting or carcinogenic agent at least in some circumstances.
FRTC cells have several characteristics similar to FRTL-5 cells, such as Tg production and the expression of Tg, TPO and TSH receptor mRNA, although proliferation of FRTC cells was independent of TSH. Previous reports have shown that transformed FRTL-5 cells usually lose differentiation markers and TSH growth dependence (Fusco et al, 1981; Sugawa et al, 1989; Berlingieri et al, 1990) . Wollman (1963) has also shown some tendency towards progressive dedifferentiation among the more differentiated thyroid tumours in rats. Differentiated human thyroid carcinomas, however, express Tg, TPO and TSH receptor mRNA to varying degrees (Brabant et al, 1991; Ohta et al, 1991) . Similar to FRTL-5 cells and some of previously reported mutant clones (Tramontano et al, 1986a; Endo et al, 1990) , FRTC cells produced cAMP and Tg in a dose-dependent manner when stimulated with TSH. Although this indicates that TSH may still continue to act as a stimulator of Tg production in FRTC cells, the elevated basal Tg levels and poor response of Tg to TSH stimulation also suggest a possibility that FRTC may be able to produce Tg, at least in part, independently of TSH. The discrepancy between TSHindependent proliferation and TSH-dependent increase in cAMP production in FRTC cells indicates that a signal transduction pathway(s) other than the TSH-cAMP-mediated pathway may primarily affect their growth. Although EGF may be a candidate growth factor for thyroid cells (Roger and Dumont, 1982; Westermark and Westermark, 1982) , the proliferation of FRTC cells was not markedly enhanced by EGF stimulation.
The histological patterns of FRTC tumours exhibited considerable stability from generation to generation. However, the expression of Tg mRNA in the tumours of the 12th generation decreased compared with those of the third generation, indicating that there may be a tendency towards dedifferentition in FRTC. It is of interest that there was no change in the expression of TSH receptor mRNA between these tumours. This is compatible with the previous report that TSH receptor mRNA expression is retained much further along the pathway of transformation than the expression of function-related genes, such as Tg or TPO (Brabant et al, 1991) .
It is of interest that the expression of TSH receptor mRNA increased after TSH stimulation in FRTC cells, but decreased in FRTL-5 cells, as reported previously . In normal and abnormal human thyroid cells obtained from patients with adenomas or papillary cancers, expression levels of TSH receptor mRNA have been reported to increase after TSH stimulation in vitro (Huber et al, 1991) . Maenhaut et al (1992) reported that TSH mRNA levels in dog thyrocytes increased after the TSH stimulation for 20 h, but decreased afterwards. They also reported that neither 2-day forskolin stimulation nor 6 h treatment with TSH or forskolin in vitro had any influence on the TSH mRNA expression in human thyroid cells. The basis of this discrepancy, however, is unknown. In thyroid papillary or follicular carcinoma tissues, TSH receptor mRNA levels have been reported to vary from normal to markedly decreased (Brabant et al, 1991; Ohta et al, 1991) . TSH receptor mRNA levels were high in benign thyroid tumours but not detectable in anaplastic cancers, indicating that the expression of TSH receptor mRNA levels may be dependent on the differentiation of thyroid cells.
Proto-oncogenes, such as c-myc and c-fos, were expressed in FRTC cells even in the absence of TSH stimulation. These protooncogenes were expressed at higher levels in vivo than in vitro. FRTL-5 cells have been reported to express these proto-oncogenes for a brief period when stimulated with TSH or dibutyryl cAMP (Colletta et al, 1986; Tramontano et al, 1986b) , although others have shown that EGF, but not TSH, stimulates the expression of cfos and c-myc mRNA in primary porcine thyroid cell cultures (Heldin and Westermark, 1988) . In human thyroid cancer tissues, it has been reported that c-myc or c-fos mRNA is expressed at varying levels (Wyllie et al, 1989; Brabant et al, 1991) . FRTC cells persistently express c-myc or c-fos mRNA in vitro without TSH stimulation. The persistent activation of c-myc or c-fos may induce unlimited proliferation of FRTC cells in the absence of TSH.
FRTC cells retain many characteristics of differentiated thyroid cancer cells and are transplantable to syngeneic Fisher rats. Although the mechanism of malignant transformation with MDP remains unknown, FRTC may be a useful cell line for the investigation of differentiated thyroid cancer.
